Pulmonary Fibrosis

Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis

Role of Genetic Factors in the Development of Lung Disease

Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

Interstitial Lung Disease Research Unit Biobank

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Analysis of Specimens From Individuals With Pulmonary Fibrosis

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

Safety of Bronchoscopy in Patients With Interstitial Lung Disease

Implementation of Home Monitoring in Patients With Pulmonary Fibrosis

P4O2 ILD Extension

This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across a Wide Variety of Pulmonary Fibrosis Subtypes, With the Aim of Providing Clinicians With Assurance That This is an Appropriate Therapeutic Combination.

DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSIS

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

Advanced Imaging for Pulmonary Fibrosis

Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment

Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

Clinical Application of 68Ga-1A12 PET in Fibrosis-related Diseases